(Q40606533)

22 September 2017

title

Biomarkers: evaluation of clinical utility in surveillance and early diagnosis for hepatocellular carcinoma (English)

1 reference

22 September 2017

0 references

1

Peipei Song

1 reference

22 September 2017

Qi Tang

2

1 reference

22 September 2017

Xiaobin Feng

series ordinal

3

1 reference

22 September 2017

Wei Tang

series ordinal

4

1 reference

22 September 2017

publication date

20 July 2016

1 reference

The Scandinavian journal of clinical & laboratory investigation. Supplementum

22 September 2017

published in

1 reference

22 September 2017

volume

245

1 reference

22 September 2017

page(s)

S70-6

1 reference

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

Recent advances in surgical treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

Liver transplantation and autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

Liver transplantation for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

The influence of histological differentiation grade on the outcome of liver resection for hepatocellular carcinomas 2 cm or smaller in size

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

Systemic therapies for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

Adjuvant sorafenib reduced mortality and prolonged overall survival and post-recurrence survival in hepatocellular carcinoma patients after curative resection: a single-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

Hepatocellular carcinoma: Advances in diagnostic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

The management of hepatocellular carcinoma around the world: a comparison of guidelines from 2001 to 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

High-sensitivity Lens culinaris agglutinin-reactive alpha-fetoprotein assay predicts early detection of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

Perspectives on a combined test of multi serum biomarkers in China: towards screening for and diagnosing hepatocellular carcinoma at an earlier stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

Identification of osteopontin as a novel marker for early hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

Evaluation of midkine as a diagnostic serum biomarker in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

MicroRNAome genome: a treasure for cancer diagnosis and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

Hepatocellular carcinoma in the Asia pacific region

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

Biomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and china

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

Diagnostic value of protein induced by vitamin K absence (PIVKAII) and hepatoma-specific band of serum gamma-glutamyl transferase (GGTII) as hepatocellular carcinoma markers complementary to alpha-fetoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

Clinical utility of simultaneous measurement of alpha-fetoprotein and des-γ-carboxy prothrombin for diagnosis of patients with hepatocellular carcinoma in China: A multi-center case-controlled study of 1,153 subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365513.2016.1210328

10.1080/00365513.2016.1210328

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference